Vulnerabilities

Vulnerability · CVE-2026-20046

A vulnerability in task group assignment for a specific CLI command in Cisco IOS XR Software could allow an authenticated, local attacker to elevate privileges and gai…

Published Mar 11, 2026 · catalog updated Jul 1, 2026 · ios xr

Check if you run it

No confirmed exploitation is on record for CVE-2026-20046. EPSS is 0.14%. Act only if a listed version of ios xr is installed.

Gaps on this record

  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High8.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.14%
Remediation
Advisory link
Affected products
cpe cisco/ios xr

A vulnerability in task group assignment for a specific CLI command in Cisco IOS XR Software could allow an authenticated, local attacker to elevate privileges and gain full administrative control of an affected device. This vulnerability is due to incorrect mapping of a command to task groups within the source code. An attacker with a low-privileged account could exploit this vulnerability by using the CLI command to bypass the task group–based checks. A successful exploit could allow the attacker to elevate privileges and perform actions on an affected device without authorization checks.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe cisco/ios xrversion unspecified

How to fix CVE-2026-20046

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-20046. EPSS is 0.14%. Act only if a listed version of ios xr is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-264. EPSS 0.14%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 11, 2026 · NIST NVD

    Detected

    A vulnerability in task group assignment for a specific CLI command in Cisco IOS XR Software could allow an authenticated, local attacker to elevate privileges and gain full administrative control of an affected device. This vulnerability is due to incorrect mapping of a command to task groups within the source code. An attacker with a low-privileged account could exploit this vulnerability by usi

  2. Jul 1, 2026 · NIST NVD

    Updated

    A vulnerability in task group assignment for a specific CLI command in Cisco IOS XR Software could allow an authenticated, local attacker to elevate privileges and gain full administrative control of an affected device. This vulnerability is due to incorrect mapping of a command to task groups within the source code. An attacker with a low-privileged account could exploit this vulnerability by usi

Sources

  • CVE.orgVulnerability recordCVE-2026-20046

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-20046

    30-day exploitation probability 0.1%

    first.org
  • NIST NVDVulnerability recordCVE-2026-20046

    A vulnerability in task group assignment for a specific CLI command in Cisco IOS XR Software could allow an authenticated, local attacker to elevate privileges and gain full administrative control of an affected device. This vulnerability is due to incorrect mapping of a comma

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.